Results 81 to 90 of about 942,314 (272)

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

REPORT OF THE GRAVITY MEASUREMENT BY THE JAPANESE ANTARCTIC RESEARCH EXPEDITION, 1959-60

open access: yesAntarctic Record, 1961
Gravity value at Astronomical point, Syowa station, was determined by observations with a WORDEN gravimeter in the third Japanese Antarctic Research Expedition 1958-59, and the following result has been obtained: g_=982.540cm/sec^2 Latitude 69°00'4S ...
Hiromiti SUZUKI   +2 more
doaj   +1 more source

Geographic and temporal trends in fentanyl-detected deaths in Connecticut, 2009-2019 [PDF]

open access: gold, 2022
Haidong Lu   +3 more
openalex   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

open access: yesArthritis Care &Research, Accepted Article.
Objectives Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition, with widely varying global prevalence estimates. Frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the US or UK at 19‐39 per 100,000 as opposed to 65‐97 per 100,000.
Lucinda Roper   +7 more
wiley   +1 more source

Risk of Retinopathy Associated with Long‐Term Use of Hydroxychloroquine in Patients with Rheumatic Diseases: A Systematic Review and Meta‐Analysis

open access: yesArthritis Care &Research, Accepted Article.
Objective We aimed to estimate the prevalence and cumulative incidence of hydroxychloroquine retinopathy (HCQ‐R) and its risk factors among long‐term HCQ users with rheumatic diseases through a systematic review and meta‐analysis of observational studies that used spectral‐domain OCT (SD‐OCT) for screening. Methods A systematic search of PubMed, Scopus,
Narsis Daftarian   +4 more
wiley   +1 more source

Insecticidal and repellent activity of essential oil from Amomum villosum Lour. and its main compounds against two stored-product insects

open access: yesInternational Journal of Food Properties, 2018
The Amomum villosum essential oil was obtained from hydrodistillation and was investigated by GC-MS. The main constituents were bornyl acetate (51.6%), camphor (19.8%), camphene (8.9%) and limonene (6.2%).
Zhen-yang Chen   +7 more
doaj   +1 more source

High Healthcare Utilization Preceding Diagnosis with Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, Accepted Article.
Objective Though early diagnosis improves long‐term outcomes, Juvenile Idiopathic Arthritis (JIA) patients often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize healthcare utilization in the year preceding diagnosis.
Anna Costello   +5 more
wiley   +1 more source

Integrating Patient‐Reported Quality Measures in SLE: Development of the American College of Rheumatology Implementation Guide

open access: yesArthritis Care &Research, Accepted Article.
Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcomes measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semi‐structured interviews ...
Catherine Nasrallah   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy